Materialise and implant manufacturer Exactech have partnered to make products for patients with severe shoulder defects.

This includes patients with substantial glenoid bone loss for whom standard and augmented reverse shoulder implants would not lead to “sustainable results”, the companies said.

Exactech will use Materialise’s range of 3D printed titanium Glenius implants which are designed based on a patient’s specific anatomy using 3D data, simulation, and artificial intelligence.

“Demand is growing in the orthopaedic industry for personalization of medical devices,” said Brigitte de Vet, vice president of medical at Materialise. “Medical device companies adopt mass personalization by starting with high-value use cases and moving towards more high-volume applications.”